Comparative study analyzing survival and safety of bevacizumab/carboplatin/paclitaxel versus carboplatin/docetaxel in initial treatment of metastatic Her-2-negative breast cancer
El-Nahas, Tamer, Kader, Yasser, Spielmann,, Sakr, Amr, Metwally,Language:
english
Journal:
Breast Cancer: Targets and Therapy
DOI:
10.2147/bctt.s44728
Date:
June, 2013
File:
PDF, 323 KB
english, 2013